George Yancopoulos - Bd. Co-Chair, President & CSO, Director at Regeneron Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Bd. Co-Chair, President & CSO, Director
Stock Symbol
REGN on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

George Yancopoulos - trading volume in the past year for Regeneron Pharmaceuticals, Inc.

Holdings reported by George Yancopoulos for Regeneron Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 869K $882M $1,015.02 Jun 10, 2024 Direct
Common Stock 180K $183M $1,015.02 Jun 10, 2024 By Trust for Chldn.
Common Stock 56K $56.9M $1,015.02 Jun 10, 2024 by Children
Common Stock 5.9K $5.99M $1,015.02 Jun 10, 2024 By 401(k) Plan
Common Stock 0 $0 $1,015.02 Jun 10, 2024 by 2022 GRAT II
2019 Performance Stock Units 0 $844.09 Dec 11, 2023 Direct Common Stock
Non-Qualified Stock Option (right to buy) 0 Feb 15, 2024 Direct Common Stock

Transactions reported by George Yancopoulos for Regeneron Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.